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Abstract
Purpose Head and neck cancer (HNC) patients may experience fears regarding cancer recurrence (FoR) and of catching 
COVID-19. There could be unease for attending hospital clinics for face to face (F2F) examination. F2F benefit in cancer 
surveillance has to be balanced against the risk of virus transmission. This study aimed to report perceptions of fear of cancer 
and fear of COVID-19 and to report patient preference for follow-up consultation in HNC survivors during the COVID-19 
pandemic.
Methods The study ran from lockdown in England on 24th March to 29th July 2020. Patients were offered preference to 
postpone their consultation, to have it by telephone, or F2F. A postal survey was undertaken in the 2 weeks post-consultation 
(actual or postponed).
Results There were 103 patients. Initial action by consultant and patient resulted in 51 postponed consultations, 35 telephone 
consultations and 17 F2F meetings, with 10 F2F triggered by the patient. There were 58 responders to the survey and most 
(39) had a clear preference for one mode of follow-up consultation during the COVID-19 pandemic, with half (19) prefer-
ring F2F. A similar response was seen regarding their consultations in general to address unmet needs and concerns, with 
38 having a preferred mode, 29 preferring F2F. Serious fears about recurrence and COVID-19 were at relatively low levels 
with a tendency to be more concerned about recurrence.
Conclusion Any redesign of mode and frequency of out-patient follow-up in light of COVID-19 should be undertaken in 
discussion with patient groups and with individual patients.
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Introduction
There are recommendations concerning the frequency of 
patient review following treatment of head and neck cancer 
(HNC) [1–4]. These follow-up consultations traditionally 
take place face to face in clinic and allow an opportunity 
to assess treatment response, identify recurrence and man-
age complications [5]. Fear of recurrence is a key reason 
why patients attend [6] and assessment is usually performed 
by palpation and visual inspection, either directly or via 
endoscopy.
In England on the 24th March 2020, ‘lockdown’ occurred 
due to the COVID-19 pandemic. There was huge disruption 
of out-patient services. For a period, all out-patient consul-
tations were stopped [7]. To reduce transmission and infec-
tion risks, following ‘lockdown’, there was an imperative for 
non-face to face review either by telephone or telemedicine 
[8]. There was substantial fear of COVID-19 amongst the 
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population including patients, their careers, and staff [9]. 
This psychological threat led to the development of vari-
ous fear of COVID-19 questionnaires [10, 11]. For HNC 
patients, their fear of COVID-19 had to be balanced against 
their perceived risk of recurrence. Remote review has limita-
tions because it lacks the physical check and patients might 
feel that a recurrence could be missed without a physical 
examination and that a remote consultation was less reas-
suring in this regard.
As there is the potential for unease between the patients 
view of recurrence and the benefit of face to face checks 
compared to their fear of the COVID when venturing out 
to the hospital clinic, the aim of this study was to report 
perceptions of fear of cancer and fear of COVID and to 
report patient preference for follow-up consultation in head 
and neck survivors during the first months of the COVID-
19 pandemic. The hypothesis is that because of the fear of 
COVID-19 patients will trade off their fear of recurrence 
and opt for a postponement of their scheduled review or a 
non-face to face consultation. Our hope is that, by sharing 
the patients perspective this might inform not only current 
out-patient review strategies but also any changes that might 
occur to stratified follow-up when the pandemic has receded 
or is over.
Methods
Following lockdown in England on 24th March 2020, the 
hospital sent all patients expecting review consultations/
clinic appointments a standard letter informing them that 
their clinic had been postponed. This study took place from 
then up to 29th July 2020. A consecutive series of previ-
ously treated head and neck cancer patients were eligible. 
New referrals, non-cancer, and palliative patients were not 
included.
A three step approach was proposed to manage existing 
patients. First, a consultant review of the clinic list was made 
a couple of weeks in advance of the next scheduled appoint-
ment, with patients allocated into groups, either a postponed 
appointment, telephone consultation or a face to face consul-
tation. Allocation was based on the potential risk of recur-
rence and influenced by factors such as time since treat-
ment, tumour stage, resection margins, and time since last 
face to face consultation. The consultant’s secretary would 
then phone those whose consultations could be postponed to 
ascertain if they were accepting of the allocation or if they 
had a different preference. The consultant was informed if a 
patient had a problem and then either a telephone consulta-
tion was made or a clinic review arranged. A record of all 
postponed patients was made to make sure they remained 
under follow-up. Second, those allocated for telephone con-
sultation review were sent a Patient Concerns Inventory 
(PCI-HN) prompt list [8] a week beforehand together with 
the invitation about the expected call. The call would take 
place in a morning or afternoon slot as allocated, without 
stating a precise time to allow some flexibility. As usual a 
letter was written as part of the post-consultation. If needed, 
for patients with problems, a face to face consultation was 
arranged. Third, a face to face consultation was arranged 
for patients calling with an urgent problem, patients follow-
ing the telephone consultation who needed review, and also 
those who had appointments postponed and needed to be 
checked out. However, there were some study patients who 
actually took it upon themselves to ring the unit to get an 
appointment (telephone or face to face) and were not allo-
cated into groups by the consultant.
In the 2 weeks after having a first contact with the con-
sultant (telephone or face to face), or in the 2 weeks after 
the postponement, patients were sent a short questionnaire 
(Fig. 1) to complete and return. This questionnaire included 
a question previously developed for measuring fears of 
recurrence [12] and this was modified for this study into 
a question for measuring fears of COVID-19. No remind-
ers were sent. Patients were informed in the accompany-
ing letter that through this questionnaire the Trust hoped to 
gain an understanding of what method of consultation their 
patients preferred to inform the provision of their service 
in future. Clinical information retrieved from the hospital 
patient record system was anonymised and categorised as: 
age (< 55, 55–64, 65–74,75 or over), gender (male, female), 
clinical stage (early T1N0/T2N0, or late), site (oral, oro-
pharyngeal, laryngeal, other), osteoradionecrosis (Y/N), sur-
gery (Y/N), free flap (non, soft, composite), radiotherapy 
(Y/N), chemotherapy (Y/N) and time since primary diagno-
sis (< 12 months, 12–23, 24–59, 60 months or more).
Fisher’s exact test was used to compare response rates 
between patient subgroups and the Spearman correlation 
coefficient (rs) was used to assess the amount of correlation 
between fears of COVID-19 and fears of cancer returning, 
and the Kappa coefficient was used to estimate the strength 
of agreement.
Results
Clinical characteristics of the 103 study patients are shown 
in Table 1. The initial action from the consultant was to post-
pone the appointments of 51 patients, to have a telephone 
consultation with 25, to have a face to face contact with 6 
patients, and 21 rang in to make their own arrangements. 
Any changes to the initial actions are shown in Table 2. The 
outcome of all this was that scheduled appointments were 
postponed for 51, became telephone consultations for 35 
and remained face to face for 17. For the 52 patients within 
5 years of primary diagnosis 22 were postponed, 19 were 
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Fig. 1  Patient questionnaire
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by telephone and 11 were face to face; for the 51 patients 
beyond 5 years in follow-up 29 were postponed, 16 were 
by telephone and 6 were face to face. Most (10) of the 17 
face to face consultations were from patients who rang in to 
ask for them. The questionnaire had 58 responders (56%) 
with no obvious response biases by clinical characteristics 
(Table 1) nor by initial action taken by the consultant or the 
subsequent agreed type of consultation (Table 2).
When asked to think about future consultations dur-
ing the COVID-19 pandemic (Table 3) most patients were 
comfortable with having face to face contact (60% ‘likely’ 
or ‘very likely’) though nearly half seemed happy to post-
pone for a few months (43%) or to have a telephone con-
sultation (45%) and but were less drawn towards a video 
linkage (10%). The strongest level of preference for 40 of 
the 58 responders was ‘very likely’, 16 ‘likely’ and 2 ‘not 
sure’. For 39, their strongest preference was for one type 
only (19 face to face, 10 postpone, 9 telephone, 1 video), 
while 12 could not decide between two types (4 telephone 
or face, 4 postpone or face, 2 postpone or telephone, 1 
video or face, 1 telephone or video). Seven patients could 
not decide between three types (3 postpone or telephone 
Table 1  Casemix of the 103 
study patients and response to 
the study questionnaire
* Fisher’s exact test
Patients Questionnaire response P value*
% N
ALL patients 103 56 58
Gender
 Male 64 59 38 0.54
 Female 39 51 20
Age
 < 55 16 44 7 0.71
 55–64 26 62 16
 65–74 25 60 15
 ≥ 75 36 56 20
Clinical stage
 Early (T1N0 or T2N0) 42 62 26 0.42
 Late 61 52 32
 Tumour site
Oral 58 55 32 0.48
 Oropharynx 29 62 18
 Larynx 2 100 2
 Other 14 43 6
Treatment
 Surgery only 33 55 18 0.30
 Radiotherapy only 10 80 8
 Radiotherapy and chemotherapy 13 46 6
 Surgery and radiotherapy 41 51 21
 Surgery and radiotherapy and chemotherapy 6 83 5
Free-flap transfer(surgery only)
 Composite 12 58 7 0.61
 Soft 24 63 15
 None 44 50 22
Review status
 Primary cancer only 56 54 30
 Recurrence/2nd primary 17 59 10 0.83
 ORN only 30 60 18
Months from primary diagnosis
 < 12 12 50 6 0.59
 12–23 12 75 9
 24–59 28 54 15
 ≥ 60 51 55 28
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or face, 3 postpone or telephone or video, 1 telephone, 
video or face).
When asked to think about their consultations in gen-
eral and how well each approach would help address their 
needs/concerns (Table 3) more patients felt that face to 
face provided this (69% ‘somewhat’ or ‘very much’) than 
the other options (29% telephone, 26% postpone, 16% 
video). The strongest level of preference for 41 of the 58 
was ‘very much’, 10 ‘somewhat’, 6 ‘neutral’ and 1 ‘not 
much’. For 38, their strongest feeling was for one type only 
(29 face to face, 4 postpone, 4 telephone, 1 video), while 
13 could not decide between two types (3 telephone or 
face, 3 postpone or face, 2 postpone or telephone, 2 video 
or face, 2 telephone or video, 1 postpone or video). Four 
patients could not decide between three types (postpone 
or telephone or face) and 3 could not decide between all 
four types (1 ‘somewhat’ for all, 1 ‘neutral’ for all, 1 ‘not 
much’ for all).
Fears of getting the COVID-19 virus were slightly lower 
than fears of cancer recurrence (Table 4) in that 34 had little 
or no fears of the virus compared to 21 of having recur-
rence. Similar numbers (7 virus, 9 recurrence) either had a 
lot of fears or were fearful all the time, with 4 patients hav-
ing significant fears for both and 12 patients with either or 
both. The actual type of clinic initially agreed with these 12 
patients was to postpone for 6, to hold a telephone consulta-
tion for 4 and to meet face to face for 2. Spearman correla-
tion between the two types of fear was rs = 0.54, p < 0.001. 
The kappa coefficient of 0.27 indicated a less than moderate 
level of agreement; 28 patients had the same level of fear 
for both, 23 feared recurrence more than COVID-19 and 
only 7 feared COVID-19 over recurrence. For 30 patients 
Table 2  Summary of the 
initial actions decided by the 
consultant and subsequent 
changes
Table shows total number of patients (number responding to the study questionnaire)
Initial Action from 
consultant
Action changed Actual type of clinic agreed Total
No clinic Telephone Face2Face
Postponed No 42 (21) – – 42 (21)
Yes – 8 (6) 1 (0) 9 (6)
Telephone No – 14 (8) – 14 (8)
Yes 9 (7) – 2 (1) 11 (8)
Face2Face No – – 4 (3) 4 (3)
Yes – 2 (2) – 2 (2)
None: patient rang 
to get appoint-
ment
– 11 (6) 10 (4) 21 (10)
Total 51 (28) 35 (22) 17 (8) 103 (58)
Table 3  Questionnaire responses in regard to suitability of the type of consultation
Very Unlikely Unlikely Not sure Not stated Likely Very Likely % Likely/V 
likely
Thinking of future consultations during the COVID-19 pandemic, how likely are you to opt for:
Postponed for a few 
months
12 11 4 6 13 12 43
Telephone 9 11 4 8 11 15 45
Video 21 10 9 12 4 2 10
Face 2 face 2 3 8 10 12 23 60
Not at all Not much Neutral Not stated Somewhat Very Much % Some-
what /V 
much
Thinking of your consultations in general, how much do you feel that each of the approaches would help address your needs/concerns:
Postponed for a few 
months
11 9 18 5 8 7 26
Telephone 12 12 9 8 5 12 29
Video 25 6 8 10 6 3 16
Face 2 face 2 2 7 7 9 31 69
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within 5 years of primary diagnosis, 17 had the same level 
of fear for both, 12 had more fear about recurrence more 
while 1 had more fear of COVID-19; for 28 patients beyond 
5 years in follow-up, 11 had the same level of fear for both, 
11 had more fear of recurrence while 6 had more fear about 
COVID-19.
Discussion
Follow-up assessment after completion of HNC treatment 
is a fundamental aspect of care. Prior to COVID-19, there 
has been debate about how out-patient consultations could 
become more individualised and stratified [13]. The pan-
demic has accelerated the need for change as although a 
huge unexpected threat, paradoxically, the COVID-19 pan-
demic has been an opportunity to reflect on how to do things 
differently. There have been changes to how out-patient clin-
ics are performed. As fears of recurrence are an important 
element of HNC review consultations perhaps by consider-
ing both fears of COVID-19 and fears of recurrence, this 
might help inform and shape expectations. This novel study 
gained initial perceptions of a consecutive group of HNC 
patients following lockdown. The response rate was reason-
able without any obvious responder bias by clinical charac-
teristics. Unfortunately, audit approval did not allow for a 
reminder survey to be sent to non-responders. The findings 
are limited to the practice of one consultant in one hospi-
tal and although there was a range of patients by clinical 
characteristics, most were oral cancer reviews. Nearly half 
of the group were longer than 5 years in follow-up and this 
reflected the number of patients followed up for osteoradi-
onecrosis. The findings of this study might have been dif-
ferent in different cancer sites (oropharynx, larynx) and in 
patients closer to treatment. In this study, it was not possible 
to include one of the emerging fear of COVID-19 scales 
[10, 11]. The study reports the early experience of patients 
post lockdown and does not assess their long-term anxieties 
around COVID-19 and out-patient review preferences. This 
study does not include the views amongst healthcare profes-
sionals, who will have varying degree of COVID-19-related 
anxieties in terms of HNC where examination of the mouth 
and throat and the use of aerosol producing procedure such 
as nasendoscopy carry additional risk. Finally, it was not 
the intention to validate the selection criteria on favouring 
the type of review. However, there is merit to develop deci-
sion process tools to help patients and clinicians weigh up 
the need and benefit of having a consultation, whether face 
to face or virtual, or alternatively being discharged back to 
primary care. In this study no specific objective criteria were 
used to decide the initial allocation and it was a combina-
tion of factors that might suggest that recurrence was more 
likely and might be missed without physical examination. 
Thus, with this subjective approach, it is not possible to give 
sufficient level of detail or propose an algorithm that would 
allow other clinicians to make the same decision.
Given the context of the COVID-19 lockdown, it is per-
haps of little surprise that the initial tendency for both the 
patient and consultant was to postpone the appointments. 
Most of the appointments that took place were by telephone 
while most of those face to face were requested from patients 
themselves. The inference is that patients sought face to face 
if they perceived a problem. In addition, one fifth of patients 
on review contacted the clinician’s secretary to seek advice 
about their rescheduling consultation, or bring forward. This 
strategy would significantly reduce follow-ups but has the 
risk of missing asymptomatic evidence of recurrence and 
possibly earlier detection of recurrence. Previous reports 
have brought into question the reliability of patients to bring 
forward their scheduled appointment [14], but any reticence 
might be overcome if the patients have clear instruction 
regarding signs and symptoms of possible recurrence and 
a straightforward and reliable means of getting in touch. 
Although further evaluation is necessary, telephone consul-
tations could be a very convenient way to have a conversa-
tion around the patients’ progress and address any unmet 
Table 4  Questionnaire 
responses in regard to fears of 
recurrence and fears of Covid-
19
a 1. I have no fear of COVID-19, 2. I have a little fear with occasional thoughts but they don’t really bother 
me, 3. I sometimes have fearful thoughts but I can usually manage these, 4. I get a lot of fears of COVID-
19 and these can really preoccupy my thoughts, 5. I am fearful all the time of COVID-19 and I struggle 
with this
Fear of recurrence Fear of Covid-19a Total
1 2 3 4 5
1. I have no fear of recurrence 2 1 – – – 3
2. I have a little fear with occasional thoughts but they don’t really bother me 4 12 2 – – 18
3. I sometimes have fearful thoughts but I can usually manage these 2 11 12 3 – 28
4. I get a lot of fears of recurrence and these can really preoccupy my thoughts – 1 2 1 1 5
5. I am fearful all the time that my cancer might return and I struggle with this 1 – 1 1 1 4
Total 9 25 17 5 2 58
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needs. A prompt list sent out to the patient in advance of the 
consultation (Patient Concerns Inventory) could be a useful 
adjunct [8]. The patients were much less sure about video 
linked telemedicine approaches. The COVID-19 pandemic 
is likely to accelerate the wider use of this approach but 
further evaluation is needed in terms of patient preference 
and clinical benefit.
In this study, it seems that patients were less fearful of 
COVID-19 than recurrence. It is very reasonable and natu-
ral for patients to have fears and only a small number had 
substantial fears. Some patients were undecided regarding 
a preference between telephone or F2F as the mode for 
future consultations. This probably reflects uncertainly in 
regard to their future symptoms and the guidance regard-
ing virus risk during the pandemic. Their preference might 
strengthen as the perceived threat of the virus diminishes. 
It would be worthwhile repeating the study as the potential 
treat of COVID might increase or diminish depending on the 
behaviour of the pandemic. This would impact on patients 
fears related to attending consultations. However, the prem-
ise of the balance of risk, as touched on in this paper, is 
pertinent to the first wave and it is possible to tentatively 
extrapolate to future concerns and raise the issue of patient 
preference around the type of consultation. Clinicians rec-
ognise that COVID-19 has driven a change to more virtual 
clinics [15]; however, it remains unclear as to how practice 
over the long-term will change as services return to some 
sense of normalcy. The future preference of patients, as the 
pandemic wanes is uncertain, though face to face seems to 
be favoured compared to other methods. Another area of 
uncertainty is the frequency of contact and the use of scans 
to check for further HNC.
Conclusion
A better understanding of review consultation patient prefer-
ence together with the increased use of telephone and video 
consultations has potential to reduce the number of face to 
face appointments. This would free up capacity in the clinic 
setting and this is important given the issue of social distanc-
ing and time taken to clean the clinical environment and 
equipment between patients. Ongoing evaluation is needed 
and it would be beneficial to keep asking patients for their 
preference, continue to record type and frequency of review, 
and assess the clinical presentation of treatment failures and 
determine if change in out-patient follow-up strategy com-
promised this.
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